Related by context. Frequent words. (Click for all words.) 75 myelodysplastic syndrome MDS 74 acute myelogenous leukemia AML 74 relapsed refractory multiple myeloma 74 metastatic renal cell carcinoma 73 chronic lymphocytic leukemia CLL 72 metastatic hormone refractory 72 medullary thyroid cancer 72 castration resistant prostate cancer 72 HER2 positive metastatic breast 71 lupus nephritis 71 Acute Myeloid Leukemia AML 71 pheochromocytoma 71 relapsed multiple myeloma 71 pancreatic NET 70 Acute Myeloid Leukemia 70 chronic myeloid leukemia CML 70 myelodysplastic syndromes MDS 70 heavily pretreated 70 gastrointestinal stromal tumors 70 relapsed refractory 70 lymphoma CTCL 69 Irinotecan 69 indolent NHL 69 Amrubicin 69 B CLL 69 chronic myelogenous leukemia CML 69 secondary hyperparathyroidism 69 refractory multiple myeloma 69 glioblastoma multiforme GBM 69 chlorambucil 69 myelofibrosis 69 interferon alfa 69 mycophenolate mofetil 69 relapsing remitting multiple sclerosis 69 malignant pleural mesothelioma 69 hypercalcemia 69 acute myeloid leukemia AML 68 non alcoholic steatohepatitis 68 myeloid leukemia 68 bleomycin 68 IV melanoma 68 azacitidine 68 systemic lupus erythematosus SLE 68 elotuzumab 68 Chronic Lymphocytic Leukemia 68 SHPT 68 PsA 68 T2DM 68 cutaneous T cell 68 decitabine 68 cholangiocarcinoma 68 superficial bladder cancer 68 plus gemcitabine 67 luteinizing hormone releasing 67 systemic lupus erythematosus 67 Bortezomib 67 Zolinza 67 Voreloxin 67 dacarbazine 67 HGS ETR1 67 nilotinib 67 mTOR inhibitor 67 tumor lysis syndrome 67 myelodysplastic syndromes 67 octreotide 67 acne vulgaris 67 hepatocellular carcinoma HCC 67 FLT3 67 hepatitis C HCV 67 FOLFIRI 67 Lenalidomide 67 plus methotrexate 67 familial hypercholesterolemia 66 dasatinib 66 pertuzumab 66 AA amyloidosis 66 nucleoside analogue 66 romidepsin 66 androgen independent 66 breast carcinoma 66 plus dexamethasone 66 Metastatic Melanoma 66 idiopathic pulmonary fibrosis IPF 66 cabazitaxel 66 RRMS patients 66 unresectable 66 fumarate 66 tyrosine kinase inhibitor 66 Pivotal Phase III 66 chronic HCV 66 Cloretazine R VNP#M 66 vandetanib 66 orally bioavailable 65 Erlotinib 65 Carcinoma 65 Pivotal Phase 65 DOXIL 65 Alemtuzumab 65 OncoVEX GM CSF 65 myeloid 65 nonsense mutation